Jesper Fleischer

Self-monitoring of cardiac autonomic function at home is feasible

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Cardiovascular autonomic neuropathy (CAN) is associated with diabetes and may be related to the development of hypertension, ischemic stroke, and a number of other late complications. The earliest sign of CAN is a reduction of heart rate variability (HRV). Standard HRV tests for CAN include expiration-to-inspiration ratio, response to active standing (30:15), and the Valsalva maneuver. Because of the technical requirements for these tests, they are limited to the point-of-care office or a clinical laboratory setting. It is unknown if a "white-coat" phenomenon exists in autonomic neuropathy testing and if home testing is feasible. The aims of this study were (1) to evaluate the reproducibility of CAN testing in a clinical setting, (2) to evaluate the feasibility of self-monitoring of cardiovascular autonomic function at home, and (3) report possible differences in measurements taken at the hospital versus those taken at home.
OriginalsprogEngelsk
TidsskriftJournal of Diabetes Science and Technology
Vol/bind5
Nummer1
Sider (fra-til)107-12
Antal sider6
ISSN1932-2968
StatusUdgivet - 1 jan. 2011

Se relationer på Aarhus Universitet Citationsformater

ID: 34576579